<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en" article-type="retraction">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Molecular Medicine Reports</journal-id>
<journal-title-group>
<journal-title>Molecular Medicine Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1791-2997</issn>
<issn pub-type="epub">1791-3004</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/mmr.2025.13595</article-id>
<article-id pub-id-type="publisher-id">MMR-32-3-13595</article-id>
<article-categories>
<subj-group>
<subject>Retraction</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>[Retracted] Isorhamnetin inhibits IL-1&#x03B2;-induced expression of inflammatory mediators in human chondrocytes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Li</surname><given-names>Jin</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Wu</surname><given-names>Ruishan</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Qin</surname><given-names>Xiaoping</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Liu</surname><given-names>Dongyang</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Lin</surname><given-names>Fenjie</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Feng</surname><given-names>Qinglu</given-names></name>
</contrib>
</contrib-group>
<pub-date pub-type="collection"><month>09</month><year>2025</year></pub-date>
<pub-date pub-type="epub"><day>17</day><month>06</month><year>2025</year></pub-date>
<volume>32</volume>
<issue>3</issue>
<elocation-id>230</elocation-id>
<permissions>
<copyright-statement>Copyright: &#x00A9; 2025 Li et al.</copyright-statement>
<copyright-year>2025</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license>
</permissions>
</article-meta>
</front>
<body>
<p>Mol Med Rep 16: <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="retracted-article" vol="16" page="4253" id="RA1" xlink:href="10.3892/mmr.2017.7041" ext-link-type="doi">4253&#x2013;4258</related-article>, 2017; DOI: 10.3892/mmr.2017.7041</p>
<p>Following the publication of this paper, it was drawn to the Editor&#x0027;s attention by a concerned reader that certain of the western blot data shown in Fig. 3B on p. 4256 were strikingly similar to data that had already appeared in a paper written by different authors at different research institutes that had already been published in the journal <italic>OncoTargets and Therapy</italic>.</p>
<p>In view of the fact that the abovementioned data had already apparently been published prior to its submission to <italic>Molecular Medicine Reports</italic>, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused.</p>
</body>
</article>
